12.06.2015 Views

WHO Technical Report Series, No. 981 - World Health Organization

WHO Technical Report Series, No. 981 - World Health Organization

WHO Technical Report Series, No. 981 - World Health Organization

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Quality control – specifications and tests<br />

issues and was subsequently mailed out for public consultation. The comments<br />

received were collated by the secretariat for submission to the Expert Committee.<br />

It had been noted that the requirements of the monograph did not<br />

necessarily apply to preparations that were intended for any use other than by<br />

oral administration. It was pointed out that such non-oral preparations, for<br />

example, vaginal or rectal capsules, might require a special formulation, method<br />

of manufacture, or form of presentation appropriate to their particular use. Starch<br />

capsules (often known as cachets) are also not included in the monograph.<br />

The Expert Committee adopted the text as proposed.<br />

3.4.2 Proposal for revision of general monographs: parenteral preparations<br />

Following discussion at the May 2012 consultation, the draft general monograph<br />

on parenteral preparations was circulated for public consultation. The comments<br />

received were then collated by the secretariat in August and September 2012 in<br />

preparation for consideration by the Expert Committee.<br />

The proposed revisions of this general monograph were part of the review<br />

of general monographs endorsed by the Expert Committee at its forty-second<br />

meeting. Account was taken of recently adopted revised texts for 3.2 Test for<br />

sterility, 3.4 Test for bacterial endotoxins, 5.6 Extractable volume and 5.7 Test<br />

for particulate contamination.<br />

One of the major changes proposed in the revision was the required<br />

compliance of all parenteral preparations with tests for bacterial endotoxins<br />

(or, where justified, pyrogens). Consequently, a review of the individual<br />

monographs for injections is necessary, with the addition of a test and limit<br />

for bacterial endotoxins to each monograph that currently does not include<br />

such a requirement. It was noted that the requirements of the monograph<br />

did not necessarily apply to human blood and products derived from human<br />

blood, to immunological preparations, to peritoneal dialysis solutions or to<br />

radiopharmaceutical preparations.<br />

The Expert Committee proposed a number of changes to the draft and<br />

adopted the monograph subject to the amendments proposed.<br />

3.4.3 Proposal for revision of 5.1 Uniformity of<br />

content for single-dose preparations<br />

The preliminary draft of the revision of the chapter of The International<br />

Pharmacopoeia on uniformity of content for single-dose preparations was<br />

discussed at the consultation in May 2012. It was subsequently circulated for<br />

public consultation. Comments received were collated by the secretariat prior to<br />

the meeting of the Expert Committee.<br />

The Expert Committee noted that it was proposed to revise the text to<br />

bring it in line with the draft proposal for revision of the general monograph on<br />

11

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!